Fetal Monitoring Market

Fetal Monitoring Market by Product (Ultrasound, Fetal Monitors, Telemetry Devices, Fetal Electrodes), Portability (Portable, Non-portable), Method (Invasive, Non-invasive), Application (Antepartum, Intrapartum), End User, Region - Global Forecast to 2027

Report Code: MD 3253 Jan, 2023, by marketsandmarkets.com

[The global fetal monitoring market in terms of revenue was estimated to be worth $3.7 billion in 2022 and is poised to reach $5.2 billion by 2027, growing at a CAGR of 7.3% from 2022 to 2027. The advancements in technologies for fetal monitoring systems, and the growing number of obstetrics and gynecology centers are the major factors driving the fetal monitoring market’s growth.

Attractive Opportunities in the Fetal monitoring Market

Fetal Monitoring Market

e- estimated, p-projected

To know about the assumptions considered for the study, Request for Free Sample Report

Market Dynamics

Driver: Rising number of preterm births and increasing adoption of infertility treatment

Many research types have shown that the incidence of preterm births is growing due to hypertension, prolonged pre-labor rupture of membranes, antepartum hemorrhage, multiple gestations, assisted reproductive technology, short cervixes, Urinary Tract Infections (UTIs), and placenta previa, among others. There has been an adoption of advanced medical technologies in fetal monitoring systems due to The rising number of preterm births, according to the WHO, an estimated 15 million preterm births occur every year and approximately 1 million babies die each year right after birth, and the numerous neurological or physical disabilities that follow preterm births are a grave concern.

Opportunity: Development of non-invasive, portable, and advanced fetal monitors

The key manufacturers in the market are expanding their product lines to include portable and wireless monitoring systems that are accurate, safe, and affordable. For instance, in November 2021, the Shantou Institute of Ultrasonic Instruments Co., Ltd. (China) launched the Apogee 6 series of color Doppler ultrasound imaging solutions. This series included the Apogee 6200, Apogee 6300, and Apogee 6500 color Doppler ultrasound systems, that provides a solution for cardiac, abdominal, vascular, musculoskeletal, urology, and OB/GYN clinical applications.

Restraint: Availability of refurbished products

The major restraint for the growth of this market is the availability of refurbished fetal monitoring products. The companies that offer refurbished fetal monitoring products are CeviMed, SOMA TECH, Jaken Medical, and Absolute Medical Services. For cost-effectiveness various small and medium-sized hospitals opt for refurbished systems, particularly in developing countries which are price-sensitive markets. Due to these factors, there is surge in the demand for refurbished fetal monitoring and it is expected to rise in the coming years, as all these refurbished equipments offer the same functionalities as new equipment but at lower costs. This factor will hamper the revenue of companies that are offering branded fetal monitoring products in the market.

Challenge: Lack of skilled healthcare professionals

Recently, there is a shortage of professionals to deliver obstetrics, gynecology, and other preventive and reproductive healthcare services, predominantly specializing in women's health. According to The American College of Obstetricians and Gynecologists (ACOG), the demand for obstetrics and gynecology professionals is expected to increase from 50,850 to 52,660 (4%) by 2030. This means that obstetrics and gynecology efforts could increasingly focus on high-risk pregnancies, the management of complex gynecological conditions, and surgical procedures.

The fetal monitoring market is moderately consolidated. The top players— GE Healthcare (US), Siemens Healthineers (Germany), Koninklijke Philips N.V. (Netherlands), FUJIFILM SonoSite, Inc. (US), and Cardinal Health, Inc. (US)-in the fetal monitoring market accounted for a combined majority market share in 2021. There is a high degree of competition among the market players. Only major companies can afford high-capital investments as well as the high cost of R&D and manufacturing. This will prevent new entrants from entering this market.

In 2021, ultrasound devices segment accounted for the largest share of the fetal monitoring market, by products”

The fetal monitoring market is segmented into ultrasound devices, electronic maternal/fetal monitors, fetal electrodes, fetal doppler devices, uterine contraction monitors, telemetry devices, accessories & consumables, and other products. Ultrasound accounts for the major share in this market due to the increasing demand for minimally invasive gynecological treatments, and large use of ultrasound in obstetrics.

“In 2021, non-portable systems segment accounted for the largest share in the market, by portability”

The fetal monitoring market has been segmented into non-portable systems and portable systems. In 2021, the non-portable systems segment accounted for the largest share of the fetal monitoring market. Factor such as the large use of non-portable systems in hospitals and clinics which are the major end users is driving the growth of the market.

“ In 2021, non-invasive segment accounted for the largest share in the market, by method”

The fetal monitoring market has been segmented into invasive and non-invasive. In 2021, the non-invasive segment accounted for the largest share of the fetal monitoring market. The increasing incidence of high-risk pregnancies, coupled with ongoing research activities and the launch of innovative products are the factors driving the market growth.

“In 2021, antepartum segment accounted for the largest share in the market, by application”

The fetal monitoring market has been segmented into antepartum and intrapartum. In 2021, the antepartum segment accounted for the largest share of the fetal monitoring market. Antepartum is the longest time period of gestation period for fetal monitoring to diagnose any fetal abnormalities, thus, driving the market growth.

“In 2021, hospitals segment accounted for the largest share in the market, by end user”

The fetal monitoring market has been segmented into hospitals, obstetrics & gynecology clinics, and home care settings. In 2021, the hospitals segment accounted for the largest share of the fetal monitoring market. The rising government healthcare expenditure, and availability of high end facilities are the factors driving the market growth.

“ North America is the largest regional market for fetal monitoring.”

The global fetal monitoring market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2021, North America was the largest regional market for fetal monitoring. The availability of experts and availability of Neonatal Intensive Care Units (NICUs) are the major factors that supports the growth of the fetal monitoring market in North America. However, the Asia Pacific region offers high-growth opportunities for players in the fetal monitoring market. This regional segment is projected to register the highest CAGR during the forecast period. Factors such as low-weight births, and rising number of marital age individuals due to which there will be more number of pregnancies are factors driving the market growth in the region.

Fetal Monitoring Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Some key players in the fetal monitoring market (2022- 2027)

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample

Scope of the Report

Report Metric

Details

Market size available for years

2020–2027

Base year considered

2021

Forecast period

2022–2027

Forecast units

Value (USD Billion)

Segments covered

Product, Portability, Method, Application, End User, and Region

Geographies covered

North America, Europe, Asia Pacific, and Rest of the World

Companies covered

Cardinal Health, Inc. (US), Koninklijke Philips N.V. (Netherlands), GE Healthcare (US), Siemens Healthineers (Germany), FUJIFILM SonoSite, Inc. (US), Natus Medical Incorporated (US), Huntleigh Healthcare Limited (UK), The Cooper Companies Inc. (US), CONTEC Medical Systems Co., Ltd. (China), EDAN Instruments, Inc. (China), Neoventa Medical AB (Sweden), Bionet Co., Ltd. (South Korea), Progetti Srl (Italy), TRISMED Co., Ltd. (Republic of Korea), ShenZhen Luckcome Technology Inc. (China), MedGyn Products, Inc (US), Dixion (Germany), Promed Group Co., Ltd. (Hong Kong), Advanced Instrumentations (US), BRAEL-Medical Equipment (Poland), GPC Medical (India), BISTOS (Korea), Mediana Co. Ltd (Korea), Life Plus Medical (India), ChoiceMMed (China), Trivitron Healthcare (India), Dott Medical Co. Ltd. (China), Shenzhen Comen Medical Instruments Co., Ltd. (China), Shenzhen Vcomin Technology Limited (China), Nemo Healthcare (Netherlands), MindChild Medical, Inc. (US), Melody International Ltd. (Japan), Janitri Innovations Pvt. Ltd. (India), and Laerdal Global Health (Norway).

This report categorizes the fetal monitoring market into the following segments and subsegments:

By Product
  • Ultrasound Devices
  • Electronic Maternal/Fetal Monitors
  • Uterine Contraction Monitor
    • 2D Ultrasound
    • 3D/4D Ultrasound
    • Doppler Imaging
  • Fetal Electrodes
  • Fetal Doppler Devices
  • Telemetry Devices
  • Accessories and Consumables
  • Other Products
By Portability
  • Portable systems
  • Non-portable systems
By Method
  • Invasive
  • Non-Invasive
By Application
  • Antepartum
  • Intrapartum
By End User
By Region
  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • Rest of the World
    • Latin America
    • Middle East & Afric

Recent Developments

  • In May 2022, GE Healthcare (US) and Pulsenmore (Israel) signed an agreement to accelerate the adoption of Pulsenmore's home care ultrasound solutions and support their goal to pursue US FDA clearance and commercial expansion.
  • In April 2022, ArchiMed Group (France) acquired Natus Medical Incorporated (US) to expand the reach and breadth of Natus' market-leading products, reinforcing the focus on research & development and pursuing acquisitions of complementary businesses.
  • In March 2021, CONTEC Medical Systems Co., Ltd. (China) launched CMS1700B Color Doppler Ultrasonic Diagnostic System, which is mainly suitable for the diagnosis of problems in the abdomen, heart, peripheral vessels, breast, obstetrics and gynecology, small organs, urology, muscle, incretion, pediatrics, etc.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 31)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
          TABLE 1 INCLUSIONS AND EXCLUSIONS
    1.3 STUDY SCOPE 
           1.3.1 YEARS CONSIDERED
    1.4 CURRENCY CONSIDERED 
          TABLE 2 USD EXCHANGE RATES
    1.5 STAKEHOLDERS 
    1.6 SUMMARY OF CHANGES 
    1.7 LIMITATIONS 
 
2 RESEARCH METHODOLOGY (Page No. - 36)
    2.1 RESEARCH DATA 
          FIGURE 1 FETAL MONITORING MARKET: RESEARCH DESIGN METHODOLOGY
           2.1.1 SECONDARY DATA
                    2.1.1.1 Secondary sources
           2.1.2 PRIMARY DATA
                    FIGURE 2 PRIMARY SOURCES
                    TABLE 3 KEY DATA FROM PRIMARY SOURCES
                    FIGURE 3 KEY INDUSTRY INSIGHTS
                    FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
                    FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,  AND REGION
    2.2 MARKET SIZE ESTIMATION 
           2.2.1 BOTTOM-UP APPROACH
                    FIGURE 6 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
                    FIGURE 7 APPROACH 3: PARENT MARKET ANALYSIS (ULTRASOUND MARKET)
                    2.2.1.1 Growth forecast
                                FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
                                FIGURE 9 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 
          FIGURE 10 DATA TRIANGULATION METHODOLOGY
    2.4 MARKET SHARE ANALYSIS 
    2.5 STUDY ASSUMPTIONS 
    2.6 RISK ASSESSMENT 
    2.7 IMPACT OF RECESSION 
 
3 EXECUTIVE SUMMARY (Page No. - 48)
    FIGURE 11 FETAL MONITORING MARKET, BY PRODUCT, 2022 VS. 2027 (USD BILLION)
    FIGURE 12 FETAL MONITORING MARKET, BY PORTABILITY, 2022 VS. 2027 (USD BILLION)
    FIGURE 13 FETAL MONITORING MARKET, BY METHOD, 2022 VS. 2027 (USD BILLION)
    FIGURE 14 FETAL MONITORING MARKET, BY APPLICATION, 2022 VS. 2027 (USD BILLION)
    FIGURE 15 FETAL MONITORING MARKET, BY END USER, 2022 VS. 2027 (USD BILLION)
    FIGURE 16 REGIONAL SNAPSHOT OF FETAL MONITORING MARKET
 
4 PREMIUM INSIGHTS (Page No. - 52)
    4.1 FETAL MONITORING MARKET OVERVIEW 
          FIGURE 17 RISING PRETERM BIRTHS TO DRIVE FETAL MONITORING MARKET
    4.2 ASIA PACIFIC: FETAL MONITORING MARKET, BY METHOD (2021) 
          FIGURE 18 NON-INVASIVE METHODS ACCOUNTED FOR LARGEST SHARE IN 2021
    4.3 REGIONAL GROWTH OPPORTUNITIES IN FETAL MONITORING MARKET 
          FIGURE 19 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
    4.4 FETAL MONITORING MARKET: REGIONAL MIX 
          FIGURE 20 ASIA PACIFIC MARKET TO WITNESS FASTEST GROWTH DURING FORECAST PERIOD
    4.5 FETAL MONITORING MARKET: DEVELOPED VS. DEVELOPING ECONOMIES 
          FIGURE 21 DEVELOPING ECONOMIES TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 56)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 22 FETAL MONITORING MARKET DYNAMICS
           5.2.1 DRIVERS
                    5.2.1.1 Rising number of preterm births and increasing adoption of infertility treatment
                    5.2.1.2 Advanced and innovative fetal monitoring technologies
                    5.2.1.3 Government initiatives and increasing collaborations for research by health agencies
                    5.2.1.4 Reimbursement and insurance policies for fetal monitoring services
                                TABLE 4 CPT CODES FOR VAGINAL DELIVERIES
                    5.2.1.5 Active product launches by key manufacturers
                    5.2.1.6 Increasing number of obstetrics and gynecology centers for fetal monitoring
           5.2.2 RESTRAINTS
                    5.2.2.1 High costs of fetal monitoring equipment
                    5.2.2.2 Availability of refurbished products
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Development of non-invasive, portable, and advanced fetal monitors
                    5.2.3.2 Emerging markets and strengthening infrastructure
           5.2.4 CHALLENGES
                    5.2.4.1 Product recalls
                                TABLE 5 PRODUCT RECALLS IN FETAL MONITORING MARKET
                    5.2.4.2 Lack of skilled healthcare professionals
    5.3 SUPPLY CHAIN ANALYSIS 
          FIGURE 23 DIRECT DISTRIBUTION – PREFERRED STRATEGY OF PROMINENT COMPANIES
    5.4 VALUE CHAIN ANALYSIS 
          FIGURE 24 FETAL MONITORING MARKET: VALUE CHAIN ANALYSIS
    5.5 ECOSYSTEM ANALYSIS 
          FIGURE 25 FETAL MONITORING MARKET: ECOSYSTEM ANALYSIS
           5.5.1 ROLE IN ECOSYSTEM
                    FIGURE 26 KEY PLAYERS IN FETAL MONITORING MARKET ECOSYSTEM
    5.6 REGULATORY LANDSCAPE 
          TABLE 6 REGULATORY AUTHORITIES
           5.6.1 EU REGULATIONS
           5.6.2 US REGULATIONS
    5.7 PORTER'S FIVE FORCES ANALYSIS 
           5.7.1 THREAT FROM NEW ENTRANTS
           5.7.2 BARGAINING POWER OF SUPPLIERS
           5.7.3 BARGAINING POWER OF BUYERS
           5.7.4 INTENSITY OF COMPETITIVE RIVALRY
           5.7.5 THREAT OF SUBSTITUTES
    5.8 PATENT ANALYSIS OF FETAL MONITORING PRODUCTS 
          FIGURE 27 PATENT ANALYSIS: UTERINE CONTRACTION MONITORS  (2013–NOVEMBER 2022)
          FIGURE 28 PATENT ANALYSIS: FETAL DOPPLERS (2013–NOVEMBER 2022)
          FIGURE 29 PATENT ANALYSIS: FETAL ELECTRODES (2013–NOVEMBER 2022)
    5.9 TRADE ANALYSIS FOR ULTRASOUND 
           5.9.1 IMPORT DATA FOR ULTRASOUND, BY COUNTRY,  2017–2021 (USD MILLION)
           5.9.2 EXPORT DATA FOR ULTRASOUND, BY COUNTRY,  2017–2021 (USD MILLION)
    5.10 TECHNOLOGY ANALYSIS 
           TABLE 7 AVERAGE SELLING PRICE OF FETAL MONITORING PRODUCTS
 
6 FETAL MONITORING MARKET, BY PRODUCT (Page No. - 76)
    6.1 INTRODUCTION 
          TABLE 8 FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
    6.2 ULTRASOUND DEVICES 
          TABLE 9 ULTRASOUND DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 10 ULTRASOUND DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.2.1 2D ULTRASOUND
                    6.2.1.1 Increasing commercialization of innovative 2D technologies
                                TABLE 11 2D ULTRASOUND: FETAL MONITORING MARKET, BY REGION,  2020–2027 (USD MILLION)
           6.2.2 3D & 4D ULTRASOUND
                    6.2.2.1 Technological advantages of 3D & 4D ultrasound over 2D ultrasound
                                TABLE 12 3D & 4D ULTRASOUND: FETAL MONITORING MARKET, BY REGION,  2020–2027 (USD MILLION)
           6.2.3 DOPPLER IMAGING
                    6.2.3.1 Doppler imaging vital to analyze hemodynamics in fetal surveillance
                                TABLE 13 DOPPLER IMAGING: FETAL MONITORING MARKET, BY REGION,  2020–2027 (USD MILLION)
    6.3 ELECTRONIC MATERNAL/FETAL MONITORS 
           6.3.1 RISING NUMBER OF HIGH-RISK PREGNANCIES
                    TABLE 14 ELECTRONIC MATERNAL/FETAL MONITORS MARKET, BY REGION,  2020–2027 (USD MILLION)
    6.4 FETAL ELECTRODES 
           6.4.1 NEED FOR INTRAPARTUM FETAL SURVEILLANCE
                    TABLE 15 FETAL ELECTRODES MARKET, BY REGION, 2020–2027 (USD MILLION)
    6.5 FETAL DOPPLER DEVICES 
           6.5.1 INCREASING USE OF FETAL DOPPLERS IN-HOME CARE SETTINGS
                    TABLE 16 FETAL DOPPLER DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
    6.6 UTERINE CONTRACTION MONITORS 
          TABLE 17 UTERINE CONTRACTION MONITORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 18 UTERINE CONTRACTION MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.6.1 INTERNAL UTERINE CONTRACTION MONITORS
                    6.6.1.1 Accurate measurements obtained by internal UCMs
                                TABLE 19 INTERNAL UTERINE CONTRACTION MONITORS MARKET, BY REGION,  2020–2027 (USD MILLION)
           6.6.2 EXTERNAL UTERINE CONTRACTION MONITORS
                    6.6.2.1 Developments underway to overcome drawbacks of external UCMs
                                TABLE 20 EXTERNAL UTERINE CONTRACTION MONITORS MARKET, BY REGION,  2020–2027 (USD MILLION)
    6.7 TELEMETRY DEVICES 
           6.7.1 REMOTE MONITORING INCORPORATED INTO TELEMETRY DEVICES
                    TABLE 21 TELEMETRY DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
    6.8 ACCESSORIES & CONSUMABLES 
           6.8.1 ADVANCEMENTS IN FETAL MONITORING TO LEAD TO INCREASING UTILIZATION OF ACCESSORIES & CONSUMABLES
                    TABLE 22 ACCESSORIES & CONSUMABLES MARKET, BY REGION, 2020–2027 (USD MILLION)
    6.9 OTHER PRODUCTS 
          TABLE 23 OTHER PRODUCTS MARKET, BY REGION, 2020–2027 (USD MILLION)
 
7 FETAL MONITORING MARKET, BY PORTABILITY (Page No. - 89)
    7.1 INTRODUCTION 
          TABLE 24 FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
    7.2 NON-PORTABLE SYSTEMS 
           7.2.1 TECHNOLOGICAL ADVANCEMENTS IN NON-PORTABLE SYSTEMS TO SUPPORT MARKET GROWTH
                    TABLE 25 NON-PORTABLE SYSTEMS: FETAL MONITORING MARKET, BY REGION,  2020–2027 (USD MILLION)
    7.3 PORTABLE SYSTEMS 
           7.3.1 REMOTE ACCURACY OFFERED BY PORTABLE SYSTEMS TO DRIVE MARKET GROWTH
                    TABLE 26 PORTABLE SYSTEMS: FETAL MONITORING MARKET, BY REGION,  2020–2027 (USD MILLION)
 
8 FETAL MONITORING MARKET, BY METHOD (Page No. - 93)
    8.1 INTRODUCTION 
          TABLE 27 FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
    8.2 NON-INVASIVE METHOD 
           8.2.1 NON-INVASIVE METHODS WIDELY ADOPTED IN HIGH-RISK PREGNANCIES
                    TABLE 28 NON-INVASIVE FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION)
    8.3 INVASIVE METHOD 
           8.3.1 CONSISTENT TRANSMISSION OF FETAL HEART RATE POSSIBLE VIA INVASIVE METHODS
                    TABLE 29 INVASIVE FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION)
 
9 FETAL MONITORING MARKET, BY APPLICATION (Page No. - 97)
    9.1 INTRODUCTION 
          TABLE 30 FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
    9.2 ANTEPARTUM 
           9.2.1 INCREASING INCIDENCES OF PREGNANCY-RELATED COMPLICATIONS TO SUPPORT GROWTH
                    TABLE 31 ANTEPARTUM FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION)
    9.3 INTRAPARTUM 
           9.3.1 FAVORABLE GUIDELINES BY HEALTHCARE AUTHORITIES TO PROPEL GROWTH
                    TABLE 32 INTRAPARTUM FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION)
 
10 FETAL MONITORING MARKET, BY END USER (Page No. - 101)
     10.1 INTRODUCTION 
             TABLE 33 FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
     10.2 HOSPITALS 
             10.2.1 AVAILABILITY OF WELL-ESTABLISHED HEALTHCARE INFRASTRUCTURE TO DRIVE SEGMENT GROWTH
                       TABLE 34 HOSPITALS: FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION)
     10.3 OBSTETRICS & GYNECOLOGY CLINICS 
             10.3.1 RISING EMPHASIS ON PERINATAL CARE TO BOLSTER GROWTH OF SEGMENT
                       TABLE 35 OBSTETRICS & GYNECOLOGY CLINICS: FETAL MONITORING MARKET, BY REGION,  2020–2027 (USD MILLION)
     10.4 HOME CARE SETTINGS 
             10.4.1 REMOTE CARE BY PORTABLE FETAL MONITORING SYSTEMS TO DRIVE GROWTH
                       TABLE 36 HOME CARE SETTINGS: FETAL MONITORING MARKET, BY REGION,  2020–2027 (USD MILLION)
 
11 FETAL MONITORING MARKET, BY REGION (Page No. - 106)
     11.1 INTRODUCTION 
             TABLE 37 FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION)
     11.2 NORTH AMERICA 
             FIGURE 30 NORTH AMERICA: FETAL MONITORING MARKET SNAPSHOT
             TABLE 38 NORTH AMERICA: FETAL MONITORING MARKET, BY COUNTRY,  2020–2027 (USD MILLION)
             TABLE 39 NORTH AMERICA: FETAL MONITORING MARKET, BY PRODUCT,  2020–2027 (USD MILLION)
             TABLE 40 NORTH AMERICA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,  BY TYPE, 2020–2027 (USD MILLION)
             TABLE 41 NORTH AMERICA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 42 NORTH AMERICA: FETAL MONITORING MARKET, BY PORTABILITY,  2020–2027 (USD MILLION)
             TABLE 43 NORTH AMERICA: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
             TABLE 44 NORTH AMERICA: FETAL MONITORING MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
             TABLE 45 NORTH AMERICA: FETAL MONITORING MARKET, BY END USER,  2020–2027 (USD MILLION)
             11.2.1 RECESSION IMPACT
             11.2.2 US
                        11.2.2.1 US held largest share of North American market in 2021
                                      FIGURE 31 US: PRETERM BIRTH RATE, BY RACE/ETHNICITY, 2018–2020 (AVERAGE)
                                      TABLE 46 ULTRASOUND CPT CODES
                                      TABLE 47 US: FETAL MONITORING MARKET, BY PRODUCT,  2020–2027 (USD MILLION)
                                      TABLE 48 US: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,  BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 49 US: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 50 US: FETAL MONITORING MARKET, BY PORTABILITY,  2020–2027 (USD MILLION)
                                      TABLE 51 US: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
                                      TABLE 52 US: FETAL MONITORING MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                                      TABLE 53 US: FETAL MONITORING MARKET, BY END USER,  2020–2027 (USD MILLION)
             11.2.3 CANADA
                        11.2.3.1 Growing government initiatives for fetal and maternal care to drive market growth in Canada
                                      FIGURE 32 CANADA: NUMBER OF BIRTHS, 2011 TO 2021
                                      TABLE 54 CANADA: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 55 CANADA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,  BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 56 CANADA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 57 CANADA: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
                                      TABLE 58 CANADA: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
                                      TABLE 59 CANADA: FETAL MONITORING MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                                      TABLE 60 CANADA: FETAL MONITORING MARKET, BY END USER,  2020–2027 (USD MILLION)
     11.3 EUROPE 
             TABLE 61 EUROPE: FETAL MONITORING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 62 EUROPE: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             TABLE 63 EUROPE: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,  BY TYPE, 2020–2027 (USD MILLION)
             TABLE 64 EUROPE: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS,  BY TYPE, 2020–2027 (USD MILLION)
             TABLE 65 EUROPE: FETAL MONITORING MARKET, BY PORTABILITY,  2020–2027 (USD MILLION)
             TABLE 66 EUROPE: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
             TABLE 67 EUROPE: FETAL MONITORING MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
             TABLE 68 EUROPE: FETAL MONITORING MARKET, BY END USER,  2020–2027 (USD MILLION)
             11.3.1 RECESSION IMPACT
             11.3.2 GERMANY
                        11.3.2.1 Increasing healthcare expenditure to support market growth in Germany
                                      TABLE 69 GERMANY: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 70 GERMANY: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,  BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 71 GERMANY: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS,  BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 72 GERMANY: FETAL MONITORING MARKET, BY PORTABILITY,  2020–2027 (USD MILLION)
                                      TABLE 73 GERMANY: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
                                      TABLE 74 GERMANY: FETAL MONITORING MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                                      TABLE 75 GERMANY: FETAL MONITORING MARKET, BY END USER,  2020–2027 (USD MILLION)
             11.3.3 UK
                        11.3.3.1 Rising emphasis on better maternity services to drive market growth in UK
                                      TABLE 76 UK: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 77 UK: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,  BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 78 UK: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 79 UK: FETAL MONITORING MARKET, BY PORTABILITY,  2020–2027 (USD MILLION)
                                      TABLE 80 UK: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
                                      TABLE 81 UK: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 82 UK: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.3.4 FRANCE
                        11.3.4.1 Increasing focus on healthcare policies to accelerate market growth in France
                                      TABLE 83 FRANCE: HEALTHCARE SPENDING, 2011–2019
                                      TABLE 84 FRANCE: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 85 FRANCE: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,  BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 86 FRANCE: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS,  BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 87 FRANCE: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
                                      TABLE 88 FRANCE: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
                                      TABLE 89 FRANCE: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 90 FRANCE: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.3.5 ITALY
                        11.3.5.1 Increasing healthcare expenditure to propel growth of market in Italy
                                      TABLE 91 ITALY: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 92 ITALY: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,  BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 93 ITALY: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 94 ITALY: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
                                      TABLE 95 ITALY: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
                                      TABLE 96 ITALY: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 97 ITALY: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.3.6 SPAIN
                        11.3.6.1 Declining birth rate to restrain growth of market in Spain
                                      TABLE 98 SPAIN: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 99 SPAIN: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,  BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 100 SPAIN: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 101 SPAIN: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
                                      TABLE 102 SPAIN: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
                                      TABLE 103 SPAIN: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 104 SPAIN: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.3.7 REST OF EUROPE
                       TABLE 105 REST OF EUROPE: FETAL MONITORING MARKET, BY PRODUCT,  2020–2027 (USD MILLION)
                       TABLE 106 REST OF EUROPE: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,  BY TYPE, 2020–2027 (USD MILLION)
                       TABLE 107 REST OF EUROPE: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
                       TABLE 108 REST OF EUROPE: FETAL MONITORING MARKET, BY PORTABILITY,  2020–2027 (USD MILLION)
                       TABLE 109 REST OF EUROPE: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
                       TABLE 110 REST OF EUROPE: FETAL MONITORING MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                       TABLE 111 REST OF EUROPE: FETAL MONITORING MARKET, BY END USER,  2020–2027 (USD MILLION)
     11.4 ASIA PACIFIC 
            FIGURE 33 ASIA PACIFIC: FETAL MONITORING MARKET SNAPSHOT
             11.4.1 RECESSION IMPACT
                       TABLE 112 ASIA PACIFIC: FETAL MONITORING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                       TABLE 113 ASIA PACIFIC: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                       TABLE 114 ASIA PACIFIC: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,  BY TYPE, 2020–2027 (USD MILLION)
                       TABLE 115 ASIA PACIFIC: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS,  BY TYPE, 2020–2027 (USD MILLION)
                       TABLE 116 ASIA PACIFIC: FETAL MONITORING MARKET, BY PORTABILITY,  2020–2027 (USD MILLION)
                       TABLE 117 ASIA PACIFIC: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
                       TABLE 118 ASIA PACIFIC: FETAL MONITORING MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                       TABLE 119 ASIA PACIFIC: FETAL MONITORING MARKET, BY END USER,  2020–2027 (USD MILLION)
             11.4.2 JAPAN
                        11.4.2.1 Increasing focus on launch of innovative products to propel market growth in Japan
                                      TABLE 120 JAPAN: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 121 JAPAN: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE,  2020–2027 (USD MILLION)
                                      TABLE 122 JAPAN: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 123 JAPAN: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
                                      TABLE 124 JAPAN: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
                                      TABLE 125 JAPAN: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 126 JAPAN: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.4.3 CHINA
                        11.4.3.1 Developing healthcare infrastructure in China to support market growth
                                      TABLE 127 CHINA: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 128 CHINA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,  BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 129 CHINA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS,  BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 130 CHINA: FETAL MONITORING MARKET, BY PORTABILITY,  2020–2027 (USD MILLION)
                                      TABLE 131 CHINA: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
                                      TABLE 132 CHINA: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 133 CHINA: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.4.4 INDIA
                        11.4.4.1 Growing number of preterm births to drive market growth in India
                                      TABLE 134 INDIA: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 135 INDIA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,  BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 136 INDIA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS,  BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 137 INDIA: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
                                      TABLE 138 INDIA: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
                                      TABLE 139 INDIA: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 140 INDIA: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
             11.4.5 SOUTH KOREA
                        11.4.5.1 Increasing implementation of ultrasound technology to drive market in South Korea
                                      TABLE 141 SOUTH KOREA: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 142 SOUTH KOREA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,  BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 143 SOUTH KOREA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS,  BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 144 SOUTH KOREA: FETAL MONITORING MARKET, BY PORTABILITY,  2020–2027 (USD MILLION)
                                      TABLE 145 SOUTH KOREA: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
                                      TABLE 146 SOUTH KOREA: FETAL MONITORING MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                                      TABLE 147 SOUTH KOREA: FETAL MONITORING MARKET, BY END USER,  2020–2027 (USD MILLION)
             11.4.6 AUSTRALIA
                        11.4.6.1 Rising emphasis on maternal care to bolster market growth in Australia
                                      TABLE 148 AUSTRALIA: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 149 AUSTRALIA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,  BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 150 AUSTRALIA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS,  BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 151 AUSTRALIA: FETAL MONITORING MARKET, BY PORTABILITY,  2020–2027 (USD MILLION)
                                      TABLE 152 AUSTRALIA: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
                                      TABLE 153 AUSTRALIA: FETAL MONITORING MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                                      TABLE 154 AUSTRALIA: FETAL MONITORING MARKET, BY END USER,  2020–2027 (USD MILLION)
             11.4.7 REST OF ASIA PACIFIC
                       TABLE 155 REST OF ASIA PACIFIC: FETAL MONITORING MARKET, BY PRODUCT,  2020–2027 (USD MILLION)
                       TABLE 156 REST OF ASIA PACIFIC: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,  BY TYPE, 2020–2027 (USD MILLION)
                       TABLE 157 REST OF ASIA PACIFIC: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
                       TABLE 158 REST OF ASIA PACIFIC: FETAL MONITORING MARKET, BY PORTABILITY,  2020–2027 (USD MILLION)
                       TABLE 159 REST OF ASIA PACIFIC: FETAL MONITORING MARKET, BY METHOD,  2020–2027 (USD MILLION)
                       TABLE 160 REST OF ASIA PACIFIC: FETAL MONITORING MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                       TABLE 161 REST OF ASIA PACIFIC: FETAL MONITORING MARKET, BY END USER,  2020–2027 (USD MILLION)
     11.5 REST OF THE WORLD 
             11.5.1 RECESSION IMPACT
                       TABLE 162 REST OF THE WORLD: FETAL MONITORING MARKET, BY REGION,  2020–2027 (USD MILLION)
                       TABLE 163 REST OF THE WORLD: FETAL MONITORING MARKET, BY PRODUCT,  2020–2027 (USD MILLION)
                       TABLE 164 REST OF THE WORLD: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,  BY TYPE, 2020–2027 (USD MILLION)
                       TABLE 165 REST OF THE WORLD: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
                       TABLE 166 REST OF THE WORLD: FETAL MONITORING MARKET, BY PORTABILITY,  2020–2027 (USD MILLION)
                       TABLE 167 REST OF THE WORLD: FETAL MONITORING MARKET, BY METHOD,  2020–2027 (USD MILLION)
                       TABLE 168 REST OF THE WORLD: FETAL MONITORING MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                       TABLE 169 REST OF THE WORLD: FETAL MONITORING MARKET, BY END USER,  2020–2027 (USD MILLION)
             11.5.2 LATIN AMERICA
                        11.5.2.1 Favorable government policies to support growth of market
                                      TABLE 170 LATIN AMERICA: FETAL MONITORING MARKET, BY PRODUCT,  2020–2027 (USD MILLION)
                                      TABLE 171 LATIN AMERICA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,  BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 172 LATIN AMERICA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 173 LATIN AMERICA: FETAL MONITORING MARKET, BY PORTABILITY,  2020–2027 (USD MILLION)
                                      TABLE 174 LATIN AMERICA: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
                                      TABLE 175 LATIN AMERICA: FETAL MONITORING MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                                      TABLE 176 LATIN AMERICA: FETAL MONITORING MARKET, BY END USER,  2020–2027 (USD MILLION)
             11.5.3 MIDDLE EAST & AFRICA
                        11.5.3.1 High number of pre-term births recorded to boost market
                                      TABLE 177 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET, BY PRODUCT,  2020–2027 (USD MILLION)
                                      TABLE 178 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES,  BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 179 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 180 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET, BY PORTABILITY,  2020–2027 (USD MILLION)
                                      TABLE 181 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET, BY METHOD,  2020–2027 (USD MILLION)
                                      TABLE 182 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                                      TABLE 183 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET, BY END USER,  2020–2027 (USD MILLION)
 
12 COMPETITIVE LANDSCAPE (Page No. - 177)
     12.1 OVERVIEW 
     12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 
             TABLE 184 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES
     12.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 
             FIGURE 34 REVENUE SHARE ANALYSIS OF TOP PLAYERS
     12.4 MARKET SHARE ANALYSIS 
             FIGURE 35 FETAL MONITORING MARKET SHARE ANALYSIS, BY KEY PLAYER (2021)
     12.5 COMPANY EVALUATION QUADRANT (2021) 
             12.5.1 STARS
             12.5.2 EMERGING LEADERS
             12.5.3 PERVASIVE PLAYERS
             12.5.4 PARTICIPANTS
                        FIGURE 36 FETAL MONITORING MARKET: COMPANY EVALUATION QUADRANT, 2021
     12.6 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES (2021) 
             12.6.1 PROGRESSIVE COMPANIES
             12.6.2 STARTING BLOCKS
             12.6.3 RESPONSIVE COMPANIES
             12.6.4 DYNAMIC COMPANIES
                        FIGURE 37 FETAL MONITORING MARKET: START-UP/SME EVALUATION QUADRANT, 2021
     12.7 COMPETITIVE BENCHMARKING 
             TABLE 185 FETAL MONITORING MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS
             TABLE 186 PRODUCT FOOTPRINT OF KEY PLAYERS
             TABLE 187 REGIONAL FOOTPRINT OF KEY PLAYERS
     12.8 COMPETITIVE SCENARIO 
             12.8.1 PRODUCT LAUNCHES
                         TABLE 188 PRODUCT LAUNCHES, 2019–NOVEMBER 2022
             12.8.2 DEALS
                         TABLE 189 DEALS, 2019–NOVEMBER 2022
             12.8.3 OTHER DEVELOPMENTS
                         TABLE 190 OTHER DEVELOPMENTS, 2019–NOVEMBER 2022
 
13 COMPANY PROFILES (Page No. - 190)
(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *
     13.1 KEY PLAYERS 
             13.1.1 GE HEALTHCARE
                         TABLE 191 GE HEALTHCARE: BUSINESS OVERVIEW
                         FIGURE 38 GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT
                         TABLE 192 GE HEALTHCARE: PRODUCTS OFFERED
                         TABLE 193 GE HEALTHCARE: DEALS
             13.1.2 SIEMENS HEALTHINEERS
                         TABLE 194 SIEMENS HEALTHINEERS: BUSINESS OVERVIEW
                         FIGURE 39 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT
                         TABLE 195 SIEMENS HEALTHINEERS: PRODUCTS OFFERED
                         TABLE 196 SIEMENS HEALTHINEERS: DEALS
             13.1.3 CARDINAL HEALTH, INC.
                         TABLE 197 CARDINAL HEALTH, INC.: BUSINESS OVERVIEW
                         FIGURE 40 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT
                         TABLE 198 CARDINAL HEALTH, INC.: PRODUCTS OFFERED
             13.1.4 KONINKLIJKE PHILIPS N.V.
                         TABLE 199 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
                         FIGURE 41 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
                         TABLE 200 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED
                         TABLE 201 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES
             13.1.5 FUJIFILM SONOSITE, INC.
                         TABLE 202 FUJIFILM SONOSITE, INC.: BUSINESS OVERVIEW
                         FIGURE 42 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT
                         TABLE 203 FUJIFILM SONOSITE, INC.: PRODUCTS OFFERED
                         TABLE 204 FUJIFILM SONOSITE, INC.: PRODUCT LAUNCHES
                         TABLE 205 FUJIFILM SONOSITE, INC.: DEALS
             13.1.6 HUNTLEIGH HEALTHCARE LIMITED
                         TABLE 206 HUNTLEIGH HEALTHCARE LIMITED: BUSINESS OVERVIEW
                         FIGURE 43 ARJO: COMPANY SNAPSHOT
                         TABLE 207 HUNTLEIGH HEALTHCARE LIMITED: PRODUCTS OFFERED
             13.1.7 NATUS MEDICAL INCORPORATED
                         TABLE 208 NATUS MEDICAL INCORPORATED: BUSINESS OVERVIEW
                         FIGURE 44 NATUS MEDICAL INCORPORATED: COMPANY SNAPSHOT
                         TABLE 209 NATUS MEDICAL INCORPORATED: PRODUCTS OFFERED
                         TABLE 210 NATUS MEDICAL INCORPORATED: DEALS
             13.1.8 THE COOPER COMPANIES, INC.
                         TABLE 211 THE COOPER COMPANIES, INC.: BUSINESS OVERVIEW
                         FIGURE 45 THE COOPER COMPANIES, INC.: COMPANY SNAPSHOT
                         TABLE 212 THE COOPER COMPANIES, INC.: PRODUCTS OFFERED
                         TABLE 213 THE COOPER COMPANIES, INC.: DEALS
             13.1.9 CONTEC MEDICAL SYSTEMS CO., LTD.
                         TABLE 214 CONTEC MEDICAL SYSTEMS CO., LTD.: BUSINESS OVERVIEW
                         TABLE 215 CONTEC MEDICAL SYSTEMS CO., LTD.: PRODUCTS OFFERED
                         TABLE 216 CONTEC MEDICAL SYSTEMS CO., LTD.: PRODUCT LAUNCHES
                         TABLE 217 CONTEC MEDICAL SYSTEMS CO., LTD.: DEALS
             13.1.10 EDAN INSTRUMENTS, INC.
                         TABLE 218 EDAN INSTRUMENTS, INC.: BUSINESS OVERVIEW
                         TABLE 219 EDAN INSTRUMENTS, INC.: PRODUCTS OFFERED
                         TABLE 220 EDAN INSTRUMENTS, INC.: DEALS
                         TABLE 221 EDAN INSTRUMENTS, INC.: OTHER DEVELOPMENTS
     13.2 OTHER PLAYERS 
             13.2.1 NEOVENTA MEDICAL AB
             13.2.2 BIONET CO., LTD.
             13.2.3 PROGETTI SRL
             13.2.4 TRISMED CO., LTD.
             13.2.5 SHENZHEN LUCKCOME TECHNOLOGY INC., LTD.
             13.2.6 MEDGYN PRODUCTS, INC.
             13.2.7 DIXION
             13.2.8 PROMED TECHNOLOGY CO., LTD.
             13.2.9 ADVANCED INSTRUMENTATIONS
             13.2.10 BRAEL-MEDICAL EQUIPMENT
             13.2.11 GPC MEDICAL LTD.
             13.2.12 SHENZHEN VCOMIN TECHNOLOGY LIMITED
             13.2.13 BISTOS CO., LTD.
             13.2.14 MEDIANA CO., LTD.
             13.2.15 LIFE PLUS HEALTHCARE (P) LTD.
             13.2.16 CHOICEMMED
             13.2.17 TRIVITRON HEALTHCARE
             13.2.18 DOTT MEDICAL CO. LTD.
             13.2.19 SHENZHEN COMEN MEDICAL INSTRUMENTS CO., LTD.
             13.2.20 NEMO HEALTHCARE
             13.2.21 MINDCHILD MEDICAL, INC.
             13.2.22 MELODY INTERNATIONAL LTD.
             13.2.23 JANITRI INNOVATIONS PVT. LTD.
             13.2.24 LAERDAL GLOBAL HEALTH
 
*Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.
 
14 APPENDIX (Page No. - 238)
     14.1 INDUSTRY INSIGHTS 
     14.2 DISCUSSION GUIDE 
     14.3 KNOWLEDGESTORE: MARKETSANDMARKETS’  SUBSCRIPTION PORTAL 
     14.4 CUSTOMIZATION OPTIONS 
     14.5 RELATED REPORTS 
     14.6 AUTHOR DETAILS 

This study involved four major activities in estimating the current size of the fetal monitoring market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate segments and subsegments' market size.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects.

The following is a breakdown of the primary respondents:

Fetal Monitoring Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the fetal monitoring market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry have been identified through extensive secondary research
  • The revenues generated by leading players operating in the fetal monitoring market have been determined through primary and secondary research
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Global Fetal monitoring Market Size: Top-Down Approach

Fetal Monitoring Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Data Triangulation

After arriving at the overall market size applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Report Objectives

  • To define, describe, segment, and forecast the global fetal monitoring market by product, portability, method, application, end user, and region
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall fetal monitoring market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market segments with respect to five regions, namely, North America, Europe, the Asia Pacific, and Rest of the World.
  • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze company developments such as product launches, agreements, partnerships, and acquisitions in the fetal monitoring market
  • To benchmark players within the market using the proprietary "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Country Information

  • Fetal monitoring market size and growth rate estimates for countries in the Rest of Europe, the Rest of Asia Pacific, and Rest of the World.

Company profiles

  • Additional five company profiles of players operating in the fetal monitoring market.
Report Code
MD 3253
Published ON
Jan, 2023
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Fetal Monitoring Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2023 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback